All In Biotech

Drug Trial Radar · NCT00025259

Chemotherapy With or Without Additional Chemotherapy and/or Radiation Therapy in Treating Children With Newly Diagnosed Hodgkin's Disease

A Phase III Groupwide Study of Dose-Intensive Response-Based Chemotherapy and Radiation Therapy for Children and Adolescents With Newly Diagnosed Intermediate Risk Hodgkin Disease

Last checked: Nov 20, 2026Latest source record: Apr 12, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,734 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,734

Actual

Start

Sep 2002

Primary completion

Aug 2012

Sponsor

Lead sponsor
Children's Oncology GroupResearch network
Sponsor type
Research network
Collaborators
National Cancer Institute (NCI)
First posted
Jan 27, 2003

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, up to 21 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This randomized phase III trial is studying different chemotherapy regimens given with or without radiation therapy to compare how well they work in treating children with newly diagnosed Hodgkin's disease. Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Giving the drugs in different combinations may kill more cancer cells. Radiation therapy uses high-energy x-rays to damage cancer cells. It is not yet known if chemotherapy is more effective with or without additional chemotherapy and/or radiation therapy in treating Hodgkin's disease.

Conditions

  • Childhood Lymphocyte-Depleted Classical Hodgkin Lymphoma
  • Childhood Mixed Cellularity Classical Hodgkin Lymphoma
  • Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma
  • Childhood Nodular Sclerosis Classical Hodgkin Lymphoma
  • Stage I Childhood Hodgkin Lymphoma
  • Stage II Childhood Hodgkin Lymphoma
  • Stage III Childhood Hodgkin Lymphoma
  • Stage IV Childhood Hodgkin Lymphoma

Interventions

  • Bleomycin SulfateBiological

    Given IV or SC

  • CisplatinDrug

    Given IV

  • CyclophosphamideDrug

    Given IV

  • CytarabineDrug

    Given IV

  • DexamethasoneDrug

    Given IV

  • Doxorubicin HydrochlorideDrug

    Given IV

  • EtoposideDrug

    Given IV

  • FilgrastimBiological

    Given SC

  • Involved-Field Radiation TherapyRadiation

    Undergo IFRT

  • PrednisoneDrug

    Given orally

  • Vincristine Sulfate LiposomeDrug

    Given IV

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Event-free SurvivalTime frame: 5 years

Locations

175 sites in 7 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham Cancer Center

    Birmingham, Alabama

  • Phoenix Childrens Hospital

    Phoenix, Arizona

  • University of Arkansas for Medical Sciences

    Little Rock, Arkansas

  • Southern California Permanente Medical Group

    Downey, California

  • City of Hope Comprehensive Cancer Center

    Duarte, California

  • Loma Linda University Medical Center

    Loma Linda, California

  • Children's Hospital Los Angeles

    Los Angeles, California

  • Cedars-Sinai Medical Center

    Los Angeles, California

  • David Geffen School of Medicine at UCLA

    Los Angeles, California

  • Children's Hospital Central California

    Madera, California

  • Kaiser Permanente-Oakland

    Oakland, California

  • Children's Hospital of Orange County

    Orange, California

  • University of California Davis Comprehensive Cancer Center

    Sacramento, California

  • Rady Children's Hospital - San Diego

    San Diego, California

  • Santa Barbara Cottage Hospital

    Santa Barbara, California

  • Children's Hospital Colorado

    Aurora, Colorado

  • Yale University

    New Haven, Connecticut

  • Alfred I duPont Hospital for Children

    Wilmington, Delaware

  • Children's National Medical Center

    Washington D.C., District of Columbia

  • Broward Health Medical Center

    Fort Lauderdale, Florida

  • Lee Memorial Health System

    Fort Myers, Florida

  • University of Florida

    Gainesville, Florida

  • Memorial Regional Hospital/Joe DiMaggio Children's Hospital

    Hollywood, Florida

  • Nemours Children's Clinic-Jacksonville

    Jacksonville, Florida

  • University of Miami Miller School of Medicine-Sylvester Cancer Center

    Miami, Florida

  • Nicklaus Children's Hospital

    Miami, Florida

  • Baptist Hospital of Miami

    Miami, Florida

  • Florida Hospital Orlando

    Orlando, Florida

  • Nemours Children's Clinic - Orlando

    Orlando, Florida

  • All Children's Hospital

    St. Petersburg, Florida

  • Saint Joseph's Hospital/Children's Hospital-Tampa

    Tampa, Florida

  • Saint Mary's Hospital

    West Palm Beach, Florida

  • Georgia Regents University Medical Center

    Augusta, Georgia

  • University of Hawaii Cancer Center

    Honolulu, Hawaii

  • Saint Luke's Mountain States Tumor Institute

    Boise, Idaho

  • Lurie Children's Hospital-Chicago

    Chicago, Illinois

  • University of Illinois

    Chicago, Illinois

  • University of Chicago Comprehensive Cancer Center

    Chicago, Illinois

  • Loyola University Medical Center

    Maywood, Illinois

  • Advocate Lutheran General Hospital

    Park Ridge, Illinois

Showing 40 of 175 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.